SGX rejects Thomson Medical’s application to extend period for public float restoration

The company applied for a further extension on 2 January.

Thomson Medical failed to get approval from the Singapore Exchange to extend the period given to them to restore their public float.

In a bourse filing, the company said it sought another extension from the bourse on 2 January.

The first extension granted by the SGX to Thomson Medical ended on 10 January.

Despite SGX’s rejection of the company’s application, Thomson Medical said trading of its shares on the mainboard will continue.

The company also assured the public that it will continue to explore possible options to restore its public float as soon as possible.

Follow the link s for more news on

SGX

Thomson Medical

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia